Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

< Back to Article

Table 1.

Baseline patients’ characteristics and distribution of outcomes.

More »

Table 1 Expand

Fig 1.

Survival analysis.

(A) Kaplan-Meier curves for overall survival stratified by neoadjuvant chemotherapy. (B) Kaplan-Meier curves for cancer specific survival stratified by neoadjuvant chemotherapy. (C) Kaplan-Meier curves for overall survival for patients with complete response (pT0N0) vs those without complete responses (non-pT0N0). (D) Kaplan-Meier curves for cancer specific survival for patients with complete response (pT0N0) vs those without complete responses (non-pT0N0). NAC: neoadjuvant chemotherapy.

More »

Fig 1 Expand

Table 2.

Univariable, multivariable and Propensity-Weighted Regression analysis of factors predicting downstaging (<pT2N0), complete (pT0N0) pathological response and survival outcomes.

More »

Table 2 Expand

Fig 2.

Survival analysis stratified by neoadjuvant chemotherapy regimen.

(A) Kaplan-Meier curves for overall survival stratified by neoadjuvant chemotherapy regimen. (B) Kaplan-Meier curves for cancer specific survival stratified by neoadjuvant chemotherapy regimen. ddMVAC: dose-dense methotrexate, vinblastine, doxorubicin and cisplatin; NAC: neoadjuvant chemotherapy.

More »

Fig 2 Expand